Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Tropicamide recalled?

Yes — there is an active recall. 6 ongoing FDA recalls mention Tropicamide (44 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Tropicamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Tropicamide recalls on record

none so far in 2026; 44 on record, newest first
Class II · Moderate risk

Phenylephrine 2.5%

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Isomeric Pharmacy Solution, LLC D-0687-2017
Class II · Moderate risk

Tropicamide 1%/Phenylephrine 2.5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk

Tropicamide 0.5%/ Phenylephrine 5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk

Tropicamide* 1% Ophthalmic Solution

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-452-2014
Class II · Moderate risk

Phenylephrine/Tropicamide 2.5 %/1 % ophthalmic solution

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-439-2014
Class II · Moderate risk

Combo Eye Gel

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-414-2014
Class II · Moderate risk

Cyclopent/Phenyleph/Tropicamide/Proparacaine 2%/2.5%/1%/0.5% Ophthalmic 5 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1492-2012
Class II · Moderate risk

Cyclopent/Lidocaine/Phenylephrine/Tropicamide 0.5%/0.5%/0.625%/0.25% Ophthalmic 20 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1491-2012
Class II · Moderate risk

Cyclopent/Ketorolac/Phenyleph/Tropicamide 1%/0.5%/2.5%/1% Ophthalmic 70 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1490-2012
Class II · Moderate risk

Tropicamide/Phenylephrine Ophthalmic 15:1 Solution 128 Ml 480…

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1633-2012
Class II · Moderate risk

Tropicamide Ophthalmic P.F. 1% Solution 30 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1632-2012
Class II · Moderate risk

Phenylephrine/Tropicamide/Proparacaine Solution 2.5%/1%/0.5%…

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1601-2012
Class II · Moderate risk

Phenylephrine/Tropicamide

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1600-2012